Report : Middle East and Africa Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)
The CSF shunts segment by product is estimated to lead the market growth during the forecast period.
According to a new market research study of “Middle East and Africa Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, End User and Country.” The Middle East and Africa cerebrospinal fluid management market is expected to reach US$ 61.68 million by 2028 from US$ 48.08 million in 2021; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. The report highlights trends prevailing in Middle East and Africa cerebrospinal fluid management market and the factors driving market along with those that act as hindrances.
The never-ending technological developments are the unstoppable trend for the growth of CSF management market. The risk of diagnosing and treatment failure, limited control options, and complications have offered various opportunities for the product developers. Rising advancements in technology have introduced the concept of “smart shunt” that could offer hi-tech control, diagnosis, and communication-based shunts or implants. It is anticipated that designed smart shunts can control CSF drainage based on feedback from one or more measured conditions. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical shunts—data with respect to shunt malfunction. It is further expected to reduce the risk of shunt obstructions and eventually reduce the risk of failures.
Late-stage development companies operating in the market are demanding experimental results to seek approvals and commercialize the smart shunts. The primary focus is on shunts designed to assess ICP noninvasively in the physician’s office through an implanted pressure sensor and noninvasive assessment of CSF flow in the clinical settings. These on-demand sensing systems will be a significantly advanced supplement to existing mechanical valves.
The growing demand for better treatments has resulted in various product developments, resulting in the Middle East and Africa cerebrospinal fluid management market growth. For instance, in July 2018, FDA granted breakthrough device designation to F. Hoffmann-La Roche Ltd for its Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF. The products are used as in-vitro diagnostic immunoassays to measure ß-Amyloid (1-42) and Phospho-Tau concentrations in CSF among adults with cognitive impairment. They are evaluated for Alzheimer’s disease (AD) and other causes of dementia.
The COVID-19 pandemic is causing turbulence to the economies of Middle East. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflicts and cannot implement robust public health measures. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are major impacts observed in the region.
Furthermore, with widespread of the pandemic, various conferences organized by neurological societies and associations have been postponed or cancelled. The COVID-19 pandemic is further expected to stretch resources of already fragile neurosurgical systems in developing countries.
The Middle East and Africa cerebrospinal fluid management market, by product, is segmented into CSF shunts and CSF drainage systems. In 2021, the CSF shunts segment held a larger share of the market. The Middle East and Africa cerebrospinal fluid management market, by end user, is segmented into hospitals, clinics, ambulatory surgical centers, and neurological centers. Geographically, the Middle East and Africa cerebrospinal fluid management market is sub-segmented into Saudi Arabia, South Africa, UAEAnd Rest of MEA.
Medtronic, Integra Life Sciences Corporation, B. Braun Melsungen AG, DePuy Synthes, Natus Medical Incorporated and Spiegelberg GmbH & Co. KG are among the leading companies operating in the Middle East and Africa cerebrospinal fluid management market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com